Kasia A. Sablik

Clinical Relevance of Arteriolar C4d Staining in Patients With Chronic-active Antibody-mediated Rejection: A Pilot Study

D. Hesselink, M. C. Clahsen‐van Groningen, M. Betjes, 2020, Transplantation.

Banff lesions and renal allograft survival in chronic-active antibody mediated rejection.

D. Roelen, M. C. Clahsen‐van Groningen, M. Betjes, 2019, Transplant immunology.

Immune Cell Infiltrate in Chronic-Active Antibody-Mediated Rejection

M. C. Clahsen‐van Groningen, M. Betjes, E. Jordanova, 2020, Frontiers in Immunology.

Increased CD16 expression on NK cells is indicative of antibody-dependent cell-mediated cytotoxicity in chronic-active antibody-mediated rejection.

N. Litjens, M. Betjes, M. Klepper, 2019, Transplant immunology.

ARHGDIB and AT1R autoantibodies are differentially related to the development and presence of chronic antibody-mediated rejection and fibrosis in kidney allografts.

M. Betjes, N. Litjens, H. Otten, 2020, Human immunology.

Is there a clonal relationship between leukemic cells and bone marrow mesenchymal stem cells

Erasmus Mc, Erasmus MC-Sophia, Kasia A. Sablik, 2011 .

Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection

D. Hesselink, T. van Gelder, M. C. Clahsen‐van Groningen, 2018, PloS one.

Chronic‐active antibody‐mediated rejection with or without donor‐specific antibodies has similar histomorphology and clinical outcome – a retrospective study

D. Roelen, M. C. Clahsen‐van Groningen, C. Looman, 2018, Transplant international : official journal of the European Society for Organ Transplantation.

Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection

M. C. Clahsen‐van Groningen, C. Looman, M. Betjes, 2019, BMC Nephrology.